Tai Vivatvaraphol


Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.


Tai Vivatvaraphol is a counsel in O’Melveny’s Capital Markets practice group. Tai represents issuers and investment banks in a wide range of transactions, including Rule 144A and Regulation S offerings and initial public offerings. She also advises public and private companies with regard to securities law compliance, disclosure issues, and corporate governance issues, as well as both public and private mergers and acquisitions.

Prior to joining O’Melveny, Tai served as Senior Counsel at AstraZeneca, advising the global business development team in relation to acquisitions, divestments, and joint ventures.



  • French (Basic)


Bar Admissions

  • New York


  • Fordham University, J.D.: Notes & Article Editor, Fordham Law Review
  • Georgetown University, B.S.B.A., Finance and Management: cum laude